HMEJ-mediated site-specific integration of a myostatin inhibitor increases skeletal muscle mass in porcine

Main text

(Molecular Therapy: Nucleic Acids 26, 49–62; December 2021)

In the originally published version of this article, the authors found several minor errors that we wish to correct. The authors apologize for the oversight.

In figure 4B, the authors only marked the magnification of the objective lens on the picture; in fact, the combined magnification of the objective lens and eyepiece is 40×. In Figures 5H and 5J, the authors only marked the magnification of the objective lens on the picture; in fact, the combined magnification of the objective lens and eyepiece is 400×. In Figures 6A, 6C, 6I, and 6K, the β-Tubulin is misspelled as β-tublin. In Figure S2, the authors only marked the magnification of the objective lens on the picture; in fact, the combined magnification of the objective lens and eyepiece is 40×. All images and corresponding legends have been corrected in the original article online.

Figure 4. Generation of FSI-I-I knockin pigs through SCNT (original)

Figure 4. Generation of FSI-I-I knockin pigs through SCNT (corrected)

Figure 5. FSI-I-I knockin pigs exhibit increased skeletal muscle mass (original)

Figure 5. FSI-I-I knockin pigs exhibit increased skeletal muscle mass (corrected)

Figure 6. Detection of Smad, Erk, and AKT pathway proteins and myogenic regulatory factors in the longissimus dorsi of FSI-I-I knockin and wild-type pigs (original)

Figure 6. Detection of Smad, Erk, and AKT pathway proteins and myogenic regulatory factors in the longissimus dorsi of FSI-I-I knockin and wild-type pigs (corrected)

Figure S2. Comparison of transfection efficiency between BTX electroporation system (original)

Figure S2. Comparison of transfection efficiency between BTX electroporation system (corrected)